Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol + alfentanil dose-finding for painless gastroscopy by obesity status
ChiCTR2300079004Phase 4Not yet recruiting
- Sponsor
- Baoding No. 1 Central Hospital
- Start
- Dec 2023
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol and alfentanil (3 arms), sponsored by Baoding No. 1 Central Hospital. Primary endpoint: 95% effective dose. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
ciprofolalfentanil
Beyond the preview
Go deeper on ChiCTR2300079004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300079004.